William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2Gen®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- Eva exoskeleton gets a real-world test run
- STEM-Talk: Hans Van Dongen on the cognitive toll of fatigue and sleep loss
- IHMC Unveils New Leadership Team to Build on Legacy of Innovation
- Ocala Research Showcase highlights IHMC’s footprint and impact
- STEM-Talk wins Signal Award in Health & Wellness Podcasts
- STEM-Talk: Rudy Tanzi on genetics, aging, and the hallmarks of Alzheimer’s
- National Institutes of Health award for $7.7 million to determine how people over 60 attain the health benefits of exercise
- STEM-Talk: Anurag Singh on aging, exercise, and urolithin-A
- STEM-Talk: Kevin Tracey on bioelectrical medicine and inflammation’s toll